Evaluating Selected Constituents in the Exhaled Breath Samples

NCT04143256 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2020-02-11

No results posted yet for this study

Summary

An Open-Label, Multi-Center Study to Evaluate Selected Constituents in the Exhaled Breath Samples From the Use of JUUL Nicotine Salt Pod System Product (5% and 3% Virginia Tobacco, Mint, Mango, Menthol) Users and Conventional Cigarettes (Non-Menthol and Menthol Flavors)

Conditions

  • Electronic Cigarette Use
  • Cigarette Use, Electronic
  • Tobacco Use
  • Tobacco Smoking

Interventions

OTHER

JUUL ENDS 5% Virginia Tobacco

JUUL ENDS Virginia Tobacco 5% nicotine strength

OTHER

JUUL 3% Virginia Tobacco ENDS

JUUL ENDS Virginia Tobacco 3% nicotine strength

OTHER

JUUL 5% Mint ENDS

JUUL ENDS Mint 5% nicotine strength

OTHER

JUUL 3% Mint ENDS

JUUL ENDS Mint 3% nicotine strength

OTHER

JUUL 5% Menthol ENDS

JUUL ENDS Menthol 5% nicotine strength

OTHER

JUUL 3% Menthol ENDS

JUUL ENDS Menthol 3% nicotine strength

OTHER

JUUL 5% Mango ENDS

JUUL ENDS Mango 5% nicotine strength

OTHER

JUUL 3% Mango ENDS

JUUL ENDS Mango 3% nicotine strength

OTHER

US Cigarette, Non-menthol - Marlboro Gold King Size

US Cigarette, Non-menthol - Marlboro Gold King Size

OTHER

US Cigarette, Menthol - Newport King Size

US Cigarette, Menthol - Newport King Size

Sponsors & Collaborators

  • Juul Labs, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-03
Primary Completion
2019-12-12
Completion
2019-12-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04143256 on ClinicalTrials.gov